Copy
MabDesign News 
Newsletter n°10 -January 17th, 2017
View this email in your browser
In this Issue:
 
 MabDesign offers to represent your company at the BIO-EUROPE Spring congress! Check out our offer in the January zoom below! Don't miss the conferences where MabDesign can represent you in 2017!

Take a look at our next scientific events to book your agenda:
  • We'll have an exciting day in Nantes on Feb. 9th 2017, presenting the last immunoconjugates innovations that help develop personalized medicine tools. 
  • We're building an attractive program on administration routes for immunotherapy, for the workshop that will be held on April 4th, in Lyon.
  • Don't miss the 5th Antibody Industrial Symposium, a 2-day international congress that will take place in Tours, on June 27-28th, 2017. An exciting program has been set up, check it out!
     
Need a special training session this year? Have a look at MabDesign's 2017 training program and register now to benefit from reduced fees!

Don't misss the zoom on the MabDesign member ENSTBB.

Finally, learn about our members' news and see what's up around the world!
 
Wish you good reading,
MabDesign Team 

ESPECIALLY FOR YOU IN JANUARY 
MabDesign sera présent au salon BIO-EUROPE SPRING 2017 qui aura lieu du 20 au 22 Mars à Barcelone (Espagne).

MabDesign propose de vous représenter à BIO-EUROPE SPRING !

Nous pouvons présenter votre offre et réaliser des rendez-vous pour vous !
Téléchargez les offres !
Date limite de réception des demandes : 01/02/2017
Attention nombre de places limité. Contactez-nous au plus vite !

Pour plus de détails et demandes n’hésitez pas à nous contacter !
Animation scientifique organisée par MabDesign et Atlanpole Biotherapies.
 
Venez découvrir les dernières innovations en matière d'immuno-conjugués comme outils pour la thérapie, le diagnostic, l’immunomonitoring ou le développement  de tests diagnostics compagnons, afin de développer une médecine personnalisée.
 
Ils seront présents à la journée:
Easy Chelator - Atlab Pharma - Cytune Pharma - McSAF ... 
SAVE THE DATE  !!!

Animation scientifique organisée par MabDesign et Lyonbiopôle  sur le thème :
Impact des nouvelles voies d'administration sur les immunothérapies
Le 4 avril 2017 à Lyon
The AIS2017 website is now online !!! Have a look at www.ais2017.fr !
You'll soon be able to register online !
Keynote speakers :
Check out our sponsoring opportunities by clicking on the link below !
New for AIS2017 : INNOVATION AREA

 
You work for a young company, created less than 3 years ago, that has developed a technological innovation / new product. You would like to showcase your product / technology in an international congress.
The innovation area is what you need! 

To know more about our opportunities, download the Sponsor & Exhibition kit.
Sponsor and Exhibition kit
Call for abstracts:
Increase your visibility and promote innovation!

You would like to take the opportunity to present your new technology, or research project linked to ADC development? You would like to share your innovative products related to ADCs? 
We offer the opportunity to submit your abstract for a 10 min pitch presentation in a two-day international congress!!
 
Take a look at the procedure on our website or download the abstract guidelines and application form below ! 
Abstract guidelines
Abstract form
Development of therapeutic antibodies: from research to market
28th February, 1st, 16th & 17th March 2017
Paris – 4 days – Level 2
More information here !
 
Register now!
Screening of immunogenicity
5th April 2017
Lyon, during the Biovision event – 1 day and access to Biovision – Level 2
More information here !
Register now!
Using NGS technology in immunotherapy
27th April 2017
Lyon – 1 day – Level 2
More information here !
Register now!
Intellectual propriety in immunotherapy
18th May 2017
Tours – 1 day – Level 2
More information here
 

Target Product Profile
15th June 2017
Lyon or Paris – 1 day – Level 1
More information here
 

Regulatory training session: in construction
Coming in autumn 2017 – 1 day


Target Product Profile
Coming in autumn 2017 – 1 day
Want to increase your visibility and optimize your business development at conferences and trade shows in 2017? 
MabDesign can provide you with a support on 2 axis : 
  • Are you attending a specialized conference? Optimize your prospecting and your time of attendance: we help you prepare your prospecting by analyzing the participation, identifying prospects relevant to your business, and organizing appointments.  
  • You wish to be represented or accompanied in the prospecting and sales phases by a senior business developer expert in the field? In 2017, MabDesign will be present at the following events: BIOSpring (Es), Biomarker (UK), World ADC (De) , Immuno Onco Congress (UK), BIO (USA), …
 Need a tailor made proposal, do not hesitate to contact us!
 
Calendar :
ZOOM ON     
                 
ENSTBB 
Train to antibody production and analysis with ENSTBB
For more than 20 years, ENSTBB-Bordeaux INP is a biotechnology training center specialized in production, purification and analysis of therapeutic recombinant proteins, including monoclonal antibodies.
 
ENSTBB builds training programs adapted to your special needs.
ENSTBB offers a large range of professional training, from diploma to short courses, from beginners to expert, on various antibody topics. Combining successfully theory and practice, trainings are provided for small groups and on industrial lab scale equipment.
Thanks to more than 99% of satisfied trainees from 50 different companies, ENSTBB is a strong partner for training in antibody field.


Find more information here.
Contact ENSTBB
Do you know them?
 
I ABL EuropeABL Lyon I ABLIANCE I ACANTHE BIOTECH I  ACCINOV  I  ACTICOR BIOTECH  I ADVANCED BIODESIGN  I  AGILENT  I  AGUETTANT BIOTECH ANAQUANT I  ANGANY GENETICSANTINEO  I ATLANBIO I  ATLANPOLE BIOTHERAPIES  I  AXENIS  I B CELL DESIGNBIOCELLCHALLENGE  I  BIOMUNEX  I BIOTEM  I  BLINKBIOMEDICAL I  CALIXAR I CAMINNOV  I CANCER BIO SANTÉ  I  CARLINA TECH  I  CELLENION  I CISBIOCLEAN CELLS  I  COVALAB  I C.RIS PHARMA I DELPHARM BIOTECH  I  DENDRITICS  I  DYNABIO SA   I  ECRINS THERAPEUTICS  I EIVATECHELSALYS BIOTECH  I ENSTBB  I  EUROBIOMED  I  FAB'ENTECH I GAMAMABS PHARMA I GE HEALTHCARE  I GENEPEP  I  GENOWAY  I   GENTICEL  I  GLYCODIAG  I  GROUPE IMT  I  GTP TECHNOLOGY  I  HISTALIM  I  HYBRIGENICS SERVICES  I  IDD  I  IDD BIOTECH  I  INOVOTION  I  INSTITUT DE RECHERCHE PIERRE FABRE  I  LFB BIOTECHNOLOGIES  I LXREPAIR  I LYONBIOPOLE  I MAAT PHARMAMC SAF  I  MEDICEN PARIS REGION  I  MERCK BIODEVELOPMENT  I  MIMABS  I  NETRIS PHARMA  I  NOVADISCOVERY  I  NOVASEP  I  OGD2 PHARMA  I  OSE IMMUNOTHERAPEUTICS I PROMISE ADVANCED PROTEOMICS  I PROTEODYNAMICS  I  PX*THERAPEUTICS  I  RD BIOTECH  I  REPROPHARM  I  SANOFI  I  SIAMED’XPRESS  I     SYCOMORE TECHNOLOGIES  I  SYNDIVIA  I  SYNTHELIS  I TEBU-BIO  I  TRANSCURE BIOSERVICES I VETOQUINOL  I  VIBIOSPHEN  I VIROSCAN3D I VOXCAN
News about our members


January 11, 2017 – PIQUR et PIERRE FABRE annoncent un partenariat dans le domaine de la dermato-oncologie. Read more

January 6, 2017 – Facteur VII activé recombinant du LFB : le dossier de demande d'autorisation jugé recevable pour examen par la FDA (Etats-Unis). Read more

January 5, 2017 – Sanofi et Regeneron vont faire appel de la décision du tribunal de première instance américain dans le cadre du litige en cours relatif au brevet du produit injectable Praluent®(alirocumab). Read more

January 2, 2017 - Sanofi et Boehringer Ingelheim finalisent leur échange d'activités. Read more

December 28, 2016 – OSE Immunotherapeutics signe une option de licence avec Servier pour le développement et la commercialisation du produit Effi-7. Read more

December 22, 2016 - Genticel et Genkyotex annoncent leur projet de rapprochement stratégique. Read more

December 20, 2016 - Three Novasep custom manufacturing sites renew FDA approval in 2016. Read more

December 15, 2016 - ElsaLys Biotech acquires rights of Transgene’s anti-CD115 antibody. Read more

PARTNER EVENTS
World ADC Berlin
20-23 February 2017, Berlin

www.worldadc-europe.com/
 
Bringing together 60+ thought leaders in the ADC field; you will hear their lessons learned, discuss new data and debater future opportunities.
MabDesign members have an exclusive 20% discount on the registration fees.
Contact us to obtain the code !
Next Gen Immuno-Oncology Congress
London - 14-15 March 2017
This congress brings together  academicians, researcher and scientist to discuss the growth of current therapeutics and pave way for emerging next generation therapeutics.
MabDesign members have an exclusive 20% discount on registration fees.
Contact us to receive the discount code !
Other news
 
January 11, 2017 - A new HIV therapy uses DNA and antibodies to fight viral reservoirs. Read more

January 11, 2017 - Merck Receives FDA Acceptance of Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer. Read more
 
January 1, 2017 - BeiGene Announces First Patient Dosing in China Phase I Trial with Investigational Anti-PD-1 Monoclonal Antibody BGB-A317. Read more

December 27, 2016 - Immunomedics Announces Achievement of Patient Enrollment Into Single-Arm Phase 2 Study With Sacituzumab Govitecan (IMMU-132) in Triple-Negative Breast Cancer. Read more

December 23, 2016 - Acceleron Announces First Patient Treated in Phase 2 Trial of ACE-083 in Facioscapulohumeral Muscular Dystrophy. Read more

December 19, 2016 - More than ever antibody-drug conjugates generated by new technologies are undergoing clinical proof-of-concept testing. Read more

Read more News on Antibodies : PipelineReview
Copyright © 2017 - MabDesign, All rights reserved.